Iqvia Holdings (IQV) Short-term Investments (2016 - 2026)
Iqvia Holdings' (IQV) quarterly Short-term Investments came in at $171.0 million in Q2 2026, up 14.77% year-over-year from $149.0 million in Q2 2025, and up 9.62% quarter-over-quarter from $156.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Short-term Investments (2016 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Short-term Investments across 11 years of filings, most recently posting $171.0 million for Q2 2026.
- In Q2 2026, Short-term Investments rose 14.77% year-over-year to $171.0 million; the TTM figure through Jun 2026 stood at $171.0 million (up 14.77% YoY), while the FY2025 annual figure was $161.0 million, up 14.18% from the prior year.
- Short-term Investments came in at $171.0 million for Q2 2026 at Iqvia Holdings, up from $156.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $171.0 million in Q2 2026 to a low of $87.0 million in Q3 2022.
- Average Short-term Investments over 5 years is $127.4 million, with a median of $132.0 million recorded in 2024.
- Year-over-year, Short-term Investments fell 16.35% in 2022 and climbed 29.63% in 2024.
- Over 5 years, Short-term Investments stood at $93.0 million in 2022, then gained by 29.03% to $120.0 million in 2023, then advanced by 17.5% to $141.0 million in 2024, then gained by 14.18% to $161.0 million in 2025, then gained by 6.21% to $171.0 million in 2026.
- Per Business Quant data, the three most recent Short-term Investments figures were $171.0 million in Q2 2026, $156.0 million in Q1 2026, and $161.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 171.00 Mn |
| Mar 31, 2026 | 156.00 Mn |
| Dec 31, 2025 | 161.00 Mn |
| Sep 30, 2025 | 158.00 Mn |
| Jun 30, 2025 | 149.00 Mn |
| Mar 31, 2025 | 136.00 Mn |
| Dec 31, 2024 | 141.00 Mn |
| Sep 30, 2024 | 140.00 Mn |
| Jun 30, 2024 | 133.00 Mn |
| Mar 31, 2024 | 131.00 Mn |
| Dec 31, 2023 | 120.00 Mn |
| Sep 30, 2023 | 108.00 Mn |
| Jun 30, 2023 | 110.00 Mn |
| Mar 31, 2023 | 104.00 Mn |
| Dec 31, 2022 | 93.00 Mn |
| Sep 30, 2022 | 87.00 Mn |
| Jun 30, 2022 | 90.00 Mn |
| Mar 31, 2022 | 106.00 Mn |
| Dec 31, 2021 | 111.00 Mn |
| Sep 30, 2021 | 104.00 Mn |